{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T18:11:37Z","timestamp":1778091097926,"version":"3.51.4"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Analyzing the network properties of cancer biomarkers within protein\u2013protein interaction (PPI) networks is valuable for discovering novel biomarker candidates. Therefore, we constructed PPI networks using breast cancer (BC)-associated gene sets and performed 12 distinct centrality analyses to characterize the topological features of clinically validated biomarkers. Our reference set of biomarkers comprised genes from five clinical genetic testing panels\u2014MammaPrint, Oncotype DX, PAM50, EndoPredict, and the BC Index\u2014that were also present in the STRING database. The PPI networks were constructed from the top 2,000 BC-associated genes, ranked by disease score from the DISEASES database. These networks were then subjected to centrality analysis using five local and seven global measures. The top 5% centrality rankings were evaluated, demonstrating that maximum clique centrality (MCC) identified the highest proportion of known biomarkers, with an inclusion rate of approximately 36%. Furthermore, MCC generated a unique biomarker-ranking pattern, exhibiting a Spearman\u2019s rank correlation coefficient below 0.8 when compared with all other metrics. Consequently, a high MCC score is a key topological feature of many validated biomarkers. Genes with the highest MCC scores (top 5%) were significantly enriched for gene-ontology terms related to the cell cycle and fibroblast growth factor receptor signaling pathway. Additionally, biomarkers with high MCC scores exhibited significantly greater evolutionary conservation and potential for protein complex formation. Collectively, our findings indicate that many effective BC biomarkers are components of large, evolutionarily conserved cliques within cell-cycle-associated regions of the PPI network. Finally, based on this MCC-centric approach, we identified 11 novel candidate biomarkers.<\/jats:p>","DOI":"10.1371\/journal.pone.0347551","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:27:49Z","timestamp":1778088469000},"page":"e0347551","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Node properties of biomarkers within the protein\u2013protein interaction network derived from breast cancer-associated genes"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0256-1847","authenticated-orcid":true,"given":"Takanori","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saito","family":"Torii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"1","key":"pone.0347551.ref001","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"RL Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"pone.0347551.ref002","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00109.2021","article-title":"Heterogeneity within molecular subtypes of breast cancer","volume":"321","author":"KM Turner","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"issue":"23","key":"pone.0347551.ref003","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314937","article-title":"Genetic heterogeneity, tumor microenvironment and immunotherapy in triple-negative breast cancer","volume":"23","author":"E Kudelova","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"27","key":"pone.0347551.ref004","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"S Paik","year":"2004","journal-title":"N Engl J Med"},{"issue":"8","key":"pone.0347551.ref005","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"JS Parker","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6871","key":"pone.0347551.ref006","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome of breast cancer","volume":"415","author":"LJ van \u2019t Veer","year":"2002","journal-title":"Nature"},{"issue":"18","key":"pone.0347551.ref007","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1158\/1078-0432.CCR-11-0926","article-title":"A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors","volume":"17","author":"M Filipits","year":"2011","journal-title":"Clinical Cancer Research"},{"issue":"9","key":"pone.0347551.ref008","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1158\/1078-0432.CCR-07-5026","article-title":"A Five-Gene Molecular Grade Index and HOXB13:IL17BR Are Complementary Prognostic Factors in Early Stage Breast Cancer","volume":"14","author":"X-J Ma","year":"2008","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"pone.0347551.ref009","doi-asserted-by":"crossref","first-page":"897","DOI":"10.21037\/tcr-21-1920","article-title":"A narrative review of five multigenetic assays in breast cancer","volume":"11","author":"C Zeng","year":"2022","journal-title":"Transl Cancer Res"},{"key":"pone.0347551.ref010","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.2147\/OTT.S258439","article-title":"Identification of important modules and biomarkers in breast cancer based on WGCNA","volume":"13","author":"Z Tian","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"1","key":"pone.0347551.ref011","doi-asserted-by":"crossref","first-page":"21449","DOI":"10.1038\/s41598-024-72406-y","article-title":"Integrated machine learning algorithms identify KIF15 as a potential prognostic biomarker and correlated with stemness in triple-negative breast cancer","volume":"14","author":"Q Guo","year":"2024","journal-title":"Sci Rep"},{"key":"pone.0347551.ref012","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","author":"C-H Chin","year":"2014","journal-title":"BMC Syst Biol"},{"issue":"1","key":"pone.0347551.ref013","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1186\/s12859-021-04342-x","article-title":"Centrality of drug targets in protein networks","volume":"22","author":"A Viacava Follis","year":"2021","journal-title":"BMC Bioinformatics"},{"issue":"9","key":"pone.0347551.ref014","doi-asserted-by":"crossref","first-page":"954","DOI":"10.6026\/97320630019954","article-title":"Exploring potential genes and pathways related to lung cancer: a graph theoretical analysis","volume":"19","author":"S Hayat","year":"2023","journal-title":"Bioinformation"},{"issue":"6","key":"pone.0347551.ref015","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1016\/j.ygeno.2020.09.033","article-title":"Kinless hubs are potential target genes in prostate cancer network","volume":"112","author":"IR Mangangcha","year":"2020","journal-title":"Genomics"},{"key":"pone.0347551.ref016","doi-asserted-by":"crossref","first-page":"596794","DOI":"10.3389\/fgene.2021.596794","article-title":"Identifying Breast Cancer-Related Genes Based on a Novel Computational Framework Involving KEGG Pathways and PPI Network Modularity","volume":"12","author":"Y Zhang","year":"2021","journal-title":"Front Genet"},{"key":"pone.0347551.ref017","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ymeth.2014.11.020","article-title":"DISEASES: text mining and data integration of disease-gene associations","volume":"74","author":"S Pletscher-Frankild","year":"2015","journal-title":"Methods"},{"key":"pone.0347551.ref018","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baac019","article-title":"Diseases 2.0: a weekly updated database of disease-gene associations from text mining and data integration","volume":"2022","author":"D Grissa","year":"2022","journal-title":"Database (Oxford)"},{"issue":"2","key":"pone.0347551.ref019","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1021\/acs.jproteome.8b00702","article-title":"Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data","volume":"18","author":"NT Doncheva","year":"2019","journal-title":"J Proteome Res"},{"key":"pone.0347551.ref020"},{"key":"pone.0347551.ref021"},{"key":"pone.0347551.ref022"},{"issue":"7","key":"pone.0347551.ref023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021800","article-title":"REVIGO summarizes and visualizes long lists of gene ontology terms","volume":"6","author":"F Supek","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"pone.0347551.ref024","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","article-title":"An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients","volume":"123","author":"B Gy\u00f6rffy","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"pone.0347551.ref025"},{"issue":"5","key":"pone.0347551.ref026","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052622","article-title":"TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues","volume":"22","author":"\u00c1 Bartha","year":"2021","journal-title":"Int J Mol Sci"},{"key":"pone.0347551.ref027","year":"2024"},{"issue":"14","key":"pone.0347551.ref028","doi-asserted-by":"crossref","first-page":"168001","DOI":"10.1016\/j.jmb.2023.168001","article-title":"InParanoiDB 9: Ortholog Groups for Protein Domains and Full-Length Proteins","volume":"435","author":"E Persson","year":"2023","journal-title":"J Mol Biol"},{"key":"pone.0347551.ref029","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2105-4-2","article-title":"An automated method for finding molecular complexes in large protein interaction networks","volume":"4","author":"GD Bader","year":"2003","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"pone.0347551.ref030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/172460080301800403","article-title":"Functional relationship and gene ontology classification of breast cancer biomarkers","volume":"18","author":"C Arciero","year":"2003","journal-title":"Int J Biol Markers"},{"issue":"14","key":"pone.0347551.ref031","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1091\/mbc.E19-01-0013","article-title":"Unbiased Boolean analysis of public gene expression data for cell cycle gene identification","volume":"30","author":"SA Dabydeen","year":"2019","journal-title":"Molecular Biology of the Cell"},{"issue":"2","key":"pone.0347551.ref032","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng1242","article-title":"Evolutionary conservation of motif constituents in the yeast protein interaction network","volume":"35","author":"S Wuchty","year":"2003","journal-title":"Nat Genet"},{"key":"pone.0347551.ref033","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3389\/fmicb.2014.00573","article-title":"An integrated overview of spatiotemporal organization and regulation in mitosis in terms of the proteins in the functional supercomplexes","volume":"5","author":"Y Zheng","year":"2014","journal-title":"Front Microbiol"},{"issue":"12","key":"pone.0347551.ref034","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nrd1902","article-title":"Exploiting the PI3K\/AKT pathway for cancer drug discovery","volume":"4","author":"BT Hennessy","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"pone.0347551.ref035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to cancer","volume":"10","author":"N Turner","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"34","key":"pone.0347551.ref036","doi-asserted-by":"crossref","first-page":"26461","DOI":"10.1074\/jbc.M110.121491","article-title":"RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1\/ERK1\/2 activity","volume":"285","author":"C Tolg","year":"2010","journal-title":"J Biol Chem"},{"issue":"3","key":"pone.0347551.ref037","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The Fibroblast Growth Factor signaling pathway","volume":"4","author":"DM Ornitz","year":"2015","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"issue":"7","key":"pone.0347551.ref038","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrc2656","article-title":"Novel anticancer targets: revisiting ERBB2 and discovering ERBB3","volume":"9","author":"J Baselga","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"pone.0347551.ref039","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10549-013-2644-5","article-title":"Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study","volume":"140","author":"ML Slattery","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"pone.0347551.ref040","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10549-015-3670-2","article-title":"Variants of FGFR2 and their associations with breast cancer risk: a HUGE systematic review and meta-analysis","volume":"155","author":"F Cui","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"pone.0347551.ref041","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12672-024-00970-w","article-title":"Identification of hub genes and diagnostic efficacy for triple-negative breast cancer through WGCNA and Mendelian randomization","volume":"15","author":"Y Lin","year":"2024","journal-title":"Discov Oncol"},{"issue":"4","key":"pone.0347551.ref042","doi-asserted-by":"crossref","DOI":"10.3390\/cells12040525","article-title":"Potential miRNA use as a biomarker: from breast cancer diagnosis to metastasis","volume":"12","author":"E Jordan-Alejandre","year":"2023","journal-title":"Cells"},{"issue":"1","key":"pone.0347551.ref043","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.gene.2015.11.023","article-title":"A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions","volume":"577","author":"J Zhang","year":"2016","journal-title":"Gene"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0347551","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:27:57Z","timestamp":1778088477000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0347551"}},"subtitle":[],"editor":[{"given":"Attila","family":"Csik\u00e1sz-Nagy","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0347551","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]}}}